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It has been 20 years since the Orentreich Foundation for the Advancement of Science,
under the leadership Dr. Norman Orentreich, ﬁrst reported that low methionine (Met)
ingestion by rats extends lifespan (Orentreich et al., 1993). Since then, several studies
have replicated the effects of dietary methionine restricted (MR) in delaying age-related
diseases (Richie et al., 1994; Miller et al., 2005; Ables et al., 2012; Sanchez-Roman and
Barja, 2013). We report the abstracts from the First International Mini-Symposium on
Methionine Restriction and Lifespan held inTarrytown, NY, September 2013.The goalswere
(1) to gather researchers with an interest in MR and lifespan, (2) to exchange knowledge,
(3) to generate ideas for future investigations, and (4) to strengthen relationships within
this community. The presentations highlighted the importance of research on cysteine,
growth hormone (GH), and ATF4 in the paradigm of aging. In addition, the effects of dietary
restriction or MR in the kidneys, liver, bones, and the adipose tissue were discussed. The
symposium also emphasized the value of other species, e.g., the naked mole rat, Brandt’s
bat, and Drosophila, in aging research. Overall, the symposium consolidated scientists
with similar research interests and provided opportunities to conduct future collaborative
studies (Figure 3).
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Amany K. Elshorbagy (University of Oxford, UK, and University
of Alexandria, Egypt) presented “Sulfur amino acids and body
composition.” Emerging evidence from knockout studies points
to involvement of sulfur amino acids in regulation of body com-
position. Homozygous deletion of cystathionine beta-synthase,
which initiates cysteine synthesis from homocysteine, reduces
body fat in mice. Mice with a genetic defect in glutathione syn-
thesis have increased energy expenditure and resist obesity. A
similar phenotype is observed in rats fed methionine restricted
(MR) diets. Common to these models are decreased cysteine syn-
thesis and/or plasma total cysteine (tCys) and profound hepatic
suppression of the key lipogenic enzyme stearoyl-coenzyme A
desaturase-1 (SCD1). Supplementation of cysteine, but not tau-
rine, reverses the MR-induced SCD1 suppression and restores fat
gain in rats. Inmice, high cystine intake lowers energy expenditure
and up-regulates lipogenic and diabetogenic enzymes. In humans,
plasma tCys correlates with estimated SCD activity and fat mass.
Among upstream compounds, only S-adenosylmethionine shows
similarly strong associations with fat mass. In adipocytes, cys-
teine inhibits lipolysis. Pilot drug studies in mice show that
lowering cysteine concentrations can decrease the fat mass gain
caused by a high-fat diet (HFD; Figure 1). Experimental and
epidemiologic data suggest a role for sulfur amino acids in
regulation of energy metabolism, in part via an inﬂuence on
SCD1.
Martha H. Stipanuk (Cornell University, USA) presented“Reg-
ulation of cysteine dioxygenase (CDO) in response to sulfur amino
acid intake: is minimizing H2S production the goal?” The sul-
fur of sulfur-containing amino acids eventually makes its way to
inorganic sulfur or taurine as metabolic end-products that can be
excreted in the urine. Cysteine is metabolized both by a direct oxi-
dation pathway, in which the thiol group of cysteine is oxygenated
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FIGURE 1 |Total weight gain broken down into lean mass gain (white)
and fat mass gain (black) in mice after 2 weeks on a high-fat diet, with
or without a drug that lowers plasma total cysteine (Drug X).The
cysteine lowering drug halved fat mass gain without compromising lean
mass. **P < 0.001.
prior to further catabolism to either sulfate or taurine, and by
desulfhydration-oxidation pathways, in which the reduced sulfur
is released from the carbon chain as H2S/HS− or sulfane sulfur
prior to its further step-wise oxidation to sulfate. Cysteine ﬂux
through these pathways is a function primarily of the activity
of CDO, which initiates the ﬂux of cysteine through the direct
oxidative pathway, and of cysteine concentration, which is a large
determinant of ﬂux through desulfhydration pathways as well as
of CDO abundance and activity. CDO is robustly regulated in
response to cysteine availability, suggesting that control of cellular
cysteine levels is critical. Studies with Cdo1 knockout mice sug-
gest that upregulation of CDO in response to cysteine availability
serves to prevent the production of excess levels of H2S/HS− when
sulfur amino acid intake is high. Mice lacking CDO metabolize
excess cysteine by desulfhydration pathways, leading to high expo-
sure of tissues to endogenously produced H2S/HS−. These mice
exhibit postnatal growth deﬁcits and connective tissue patholo-
gies, but they also exhibit a lean phenotype, being resistant to
diet-induced obesity/insulin insensitivity. Future studies will be
aimed at deﬁning the beneﬁcial and harmful effects of elevated
H2S/HS− exposure as well as effects of the lack of hypotaurine/
taurine.
Holly M. Brown-Borg (University of North Dakota, USA)
presented “Growth hormone (GH) and methionine (Met): inter-
actions in aging and longevity.”Endocrine hormones impact aging
and aging processes in multiple ways. Circulating GH affects
not only somatic growth but also drives aspects of metabolism.
We have previously shown that GH modulates Met metabolism
in GH-deﬁcient mice. Restricting Met in rodent diets has been
shown to lower insulin-like growth factor-1 (IGF-1) and extend
lifespan. Our current studies focus on delineating the relation-
ships between dietary methionine, plasma GH status, and factors
involved in stress resistance. Our working hypothesis is that GH is
involved in the regulation of thiol metabolism that, in turn, affects
an organism’s resistance to stressors and ultimately impacts lifes-
pan. Ames dwarf, GH transgenic, and respective wild type mice
(n = 40–60/group) were subjected to dietary MR or enrichment.
Following eight weeks on the Met diets, components of the glu-
tathione and Met metabolic pathways were examined. Plasma
IGF-1 levels declined with decreasing dietary Met content. Gene
expression of Met conserving and catabolizing enzymes was dif-
ferentially affected by dietary Met level. Underlying GH status
also inﬂuenced the metabolic responses to altered dietary Met.
Lifespan studies using Ames dwarf and GH transgenic animals
subjected to diets restricted or enriched with Met are currently
underway. At this point, wild type mice respond to the Met
diets as expected, living longer on low Met vs. higher levels
(p < 0.0001); however, dwarf mice do not appear to respond
to altered Met in the diet at this point in the study. The GH
transgenic animals live much longer on MR diets when compared
to published lifespans for these animals yet do not outlive their
wild type counterparts on either of the diets tested (p < 0.0001).
The results to date suggest that the level of circulating GH inter-
acts with dietary Met and alters metabolism and lifespan in
mice.
James R. Mitchell (Harvard School of Public Health, USA)
presented “Contribution of essential amino acid restriction to
the beneﬁts of short-term dietary restriction (DR) in mice.” DR,
deﬁned as reduced food intake without malnutrition, can increase
lifespan, metabolic ﬁtness, and/or stress resistance when applied
for long periods of time in experimental organisms. However,
short-term DR lasting only one week can precondition against
clinically relevant stressors, such as ischemia reperfusion injury
seen as a frequent complication of cardiovascular surgery. Pre-
viously, we showed that removal of protein or speciﬁc essential
amino acids (tryptophan, leucine, or Met) could precondition
against surgical stress in a mouse model of renal ischemia.We also
demonstrated a genetic requirement for the amino acid depriva-
tion sensing kinase, GCN2. Here, we found that calorie restriction
and essential amino acid restriction contributed additively to the
beneﬁts of DR against surgical stress. Adding back essential amino
acids abrogated theprotection affordedbyprotein restriction inde-
pendent of their calorie content. An increase inAMPK activity and
decrease in mTORC1 activity correlated with functional beneﬁts.
These ﬁndings have translational implications for evidence-based
dietary recommendations before elective surgery and other forms
of acute stress in which ischemia reperfusion injury can play a
role.
Gene Ables (Orentreich Foundation for the Advancement of
Science, USA) presented “Metabolic effects of dietary MR in
mice.” Dietary MR in rodents extended lifespan and protected
them from developing obesity and diabetes. Since the recruit-
ment of adipose tissuemacrophages is implicated in themetabolic
syndrome, we asked whether MR reduces its accumulation. To
test this hypothesis, lean and diet-induced obese (DIO) mice
were fed isocaloric HFD containing either 0.86% (CF) or 0.12%
(MR) Met. MR mice on HFD had lower body weight despite
increased food intake. These mice were more insulin sensitive
with reduced hepatic triglyceride accumulation. These mice had
higher plasma levels of adiponectin and ﬁbroblast growth fac-
tor 21 (FGF21), while leptin, serum amyloid A (SAA) and IGF-1
levels were reduced. The hepatic genes of the MR mice showed
the down-regulation of Scd1, while Pparg, Atgl, Cd36, Jak2,
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and Fgf21 were upregulated. The smaller perigonadal adipose
tissue (PGAT) in MR mice showed lower gene expressions for
Emr1, Cd68, Ccr2, Itgam, and Tnfa and a decrease in F4/80
protein staining. The DIO-MR mice exhibited weight loss with
improved glucosemetabolism. PGATgenes showeddecreasedCcl2
expression, while Atgl was increased in the DIO-MR mice. Stain-
ing for F4/80 in the PGAT showed decreased expression in the
DIO-MR mice, which also had smaller adipocyte size. Overall,
our data suggest that MR protects mice from obesity and dia-
betes with concomitant reduction of adipose tissue macrophage
accumulation.
Tsang-Hai Huang (National Cheng Kung University, Taiwan)
presented“Effects of MR diet and endurance exercise (EXE) train-
ing on bones in male growing rats.”MR diets as well as EXE have
been mentioned to be associated with lower bone mass. Whether
this reduced bone mass represented compromise in bone qual-
ity needs to be further clariﬁed. The purpose of this study was
to investigate the effects MR and EXE on bone quality. In exper-
iment 1, young male SD rats were assigned to diets containing
0.86, 0.52, and 0.17% Met for 10 days. In a second experi-
ment, animals were assigned to six groups fed with the same
Met diets combined with or without EXE for 8 weeks. In both
experiments, the 0.17% Met fed groups showed signiﬁcant reduc-
tion in body weight, longitudinal growth, and trabecular bone
volume. Signiﬁcant down-regulation of osteocalcin was shown
in the 0.17% Met combined EXE group. Serum bone resorp-
tion markers were signiﬁcantly down-regulated due to 0.17%
Met feeding and/or EXE in both experiments. Dynamic histol-
ogy analyses revealed a signiﬁcant reduction in cortical and/or
spongy bone formation rates in 0.17% Met fed animals. And,
EXE revealed signiﬁcant down-regulation in osteoclast density.
Both MR and EXE caused lower bone mineral content (BMC)
measurements, but total BMD of 0.17% Met fed rats was sig-
niﬁcantly higher in experiment 1 and lower in 0.17% Met plus
EXE group of experiment 2. Femora of 0.17% Met fed rats
revealed signiﬁcantly lower extrinsic (whole bone level) mechan-
ical properties (e.g., bending load and energy), but no difference
(Experiment 1) and stronger (Experiment 2) in intrinsic (mate-
rial level) mechanical properties (e.g., bending stress, toughness,
and elastic modulus). Moreover, EXE provided an enhancement
effect in tissue-level properties (e.g., yield stress and tough-
ness) for the 0.86% Met fed animals. Conclusion: MR diets and
EXE showed down-regulated effects on bone/energy metabolic
indices, bone mass, and/or whole bone strength without fur-
ther compromising intrinsic bone mechanical properties. The
effects of MR and/or EXE in aging bone are worthy of further
study.
Vadim N. Gladyshev (Brigham and Women’s Hospital, Har-
vard University Medical School, USA) presented “Understanding
control of lifespan through genome analyses and methionine
status.” Understanding the mechanisms that control lifespan is
among the most challenging biological problems. Many com-
plex human diseases are associated with aging, which is both
the most signiﬁcant risk factor and the process that drives the
development of these diseases. The aging process can be regu-
lated during evolution. For instance, mammals are characterized
by >100-fold difference in lifespan, which can both increase and
decrease during evolution. We employed this diversity in mam-
malian lifespan and the associated life-history traits to shed light
on mechanisms that regulate species lifespan. For this, we uti-
lized methods of comparative genomics to examine genomes of
short- and long-lived species and carry out analysis of lifespan
across a panel of mammals. We sequenced the genomes of mam-
mals with exceptional lifespans, including the naked mole rat and
the Brandt’s bat, and identiﬁed candidate genes that may con-
tribute to their longevity. In addition, one factor that emerged
as relevant to the control of lifespan is Met availability. Indeed,
reduced Met intake can extend lifespan in rodents by mimick-
ing DR, but whether this regimen represents a general strategy
for regulating aging has been controversial. We found that MR
could extend lifespan of model organisms in the area of aging, but
this effect was limited to speciﬁc dietary conditions. These stud-
ies provide insights into the roles of Met in aging and suggest a
strategy for lifespan extension by MR. It is our hope that a better
understanding of molecular mechanisms of mammalian lifespan
control will lead to a better understanding of human diseases of
aging.
John P. Richie, Jr. (Penn State University College of Medicine,
USA) presented “Translational studies on dietary MR.” Previous
ﬁndings in rodent models that dietary MR increases maximum
lifespan and reduces the development of aging-related impair-
ments suggest that MR may have important implications as a
preventive or therapeutic strategy in humans. However, to date,
there have been few studies aimed at translating these pre-clinical
ﬁndings to the clinic. To this end, we conducted a short-term
controlled cross-over feeding study of MR in healthy adults. This
study consisted of two isocaloric diet groups (control and 86%
MR). Our objectives were to determine the feasibility of feeding
an MR diet and to assess the effects of MR on relevant blood
biomarkers. The study was conducted with 12 healthy adults
and consisted of two 3-week experimental feeding periods with
a 2-week washout (Figure 2). The MR diet was well-tolerated by
all subjects with no negative side-effects reported. Decreases in
plasma levels of Met (22%) and cysteine (15%) were observed in
the MR group after 3 weeks. MR signiﬁcantly decreased plasma
total cholesterol (15%), LDL (23%), and uric acid (25%), but
had no effects on leptin, adiponectin, IGF-1, or glutathione. Alto-
gether, these ﬁndings demonstrate the feasibility of a MR diet in
humans and indicate that MR has signiﬁcant short-term effects
on blood lipids similar to those observed in laboratory animal
FIGURE 2 | MR randomized controlled crossover feeding study design.
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FIGURE 3 | Assembled participants of the First International
Mini-Symposium on Methionine Restriction and Lifespan (Tarrytown,
NY, USA, September 8–10, 2013). Sitting in the front row (L–R): Jay
Zimmerman (Moderator), Nancy P. Durr, Norman Orentreich, David S.
Orentreich, George Roth (Keynote Speaker), Bernardita Calinao. Standing
1st row (L–R): Gene P. Ables, Ines Augie, Virginia Malloy, Herb Burack,
Blanka Rogina, Martha H. Stipanuk, Rochelle Buffenstein, Amany K.
Elshorbagy, John P. Richie. Standing 2nd row (L–R): Tsang-hai Huang,
Amadou Ouattara, Jason Plummer, Franz Perrodin, James R. Mitchell, Joel
Brind, Dwight Mattocks, Christopher D. Church. Last row (L–R): Vadim N.
Gladyshev, Boris Krasnikov, Arthur Cooper (Moderator), Holly M.
Brown-Borg, and Richard A. Miller.
models. In addition, the lack of effects on blood adipokines
and glutathione are consistent with more recent laboratory ﬁnd-
ings that indicate that restrictions in both Met and Cys may be
required for the full range of beneﬁcial effects on adipokines and
longevity.
Richard A. Miller (University of Michigan, USA) presented
“Drugs, diets, genes that extend mouse lifespan: any common
pathways?” The last 20 years have produced convincing evidence
that maximum lifespan in rodents can be increased by at least two
diets, mutation of at least half a dozen genes, and at least one drug,
rapamycin. Evidence that the longevity effect reﬂects slower aging,
rather than, say, anti-cancer effects on their own, is very strong for
caloric restriction and fairly strong for MR, several of the muta-
tions that block GH and IGF-1 signals, and rapamycin. These new
research tools allow initial studies of an interesting question: are
there “common pathways” that are altered in parallel in each of
these nominally different approaches for slowing the aging pro-
cess? This presentation focused on two candidate mechanisms:
(a) induction of enzymes that lead to detoxiﬁcation of xenobi-
otic and endogenously generated metabolites and (b) activation
of ATF4, a protein that senses blocks to translation. The talk also
presented data on four newer approaches to lifespan extension in
mice: (a) the crowded litter (CL) model, based on transient early
life nutritional deprivation; (b) acarbose, a drug that slows diges-
tion of starches to sugars and extends lifespan, principally inmales;
(c) nordihydroguaiaretic acid,NDGA,an anti-inﬂammatory agent
that extendsmale lifespan; and (d)MIF-KO,amutation that lowers
levels ofMigration Inhibitory Factor, a pro-inﬂammatory cytokine
with links to insulin secretion and response.Work now in progress
has shown that liver fromMRmice has elevations in ATF4 protein
andmultiple ATF4 target mRNAs, suggesting that further study of
the role of translation control and stress resistance in the restricted
mice may give clues to connections between diet and late-life
disease.
Rochelle Buffenstein (University of Texas Health Science Cen-
ter, USA) presented “Stress-enhanced proteostasis in long-lived
nakedmole-rats.” Improved cellular stress resistance is commonly
associated with extended species longevity, although the mecha-
nisms involved remain elusive. It is likely that these traits are linked
to dietary protein content and the efﬁcient removal of damaged
proteins. Naked mole-rats are strictly herbivorous and naturally
have a low Met diet. This lifestyle may contribute to their cancer-
free good health for 75% of their preternaturally long, 32-year
lifespan, despite high levels of oxidative stress present from an
early age. Clearly both genomic and proteomic integrity are well
maintained in this mouse-sized rodent. Unlike mice that show a
pronounced decline in the removal of damaged proteins by the
proteasome both with age and in response to stress, mole-rats
maintain four-fold higher proteasome activities than domice over
at least 75% of their lifespan. Moreover, mole-rat proteasomes
are also resistant to inhibition by proteasome-speciﬁc compet-
itive inhibitors (e.g., bortezomib) as well as oxidative stressors
such as 4-hydroxynonenal and dietary toxins such as heavymetals.
Maintaining proteasome activity and preventing their inhibition
by damaging agents, even when subjected to oxidative insults
and dietary toxins, likely contributes to their well maintained
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protein homeostasis and their concomitant ability to stave off
the progressive decline and other vagaries associated with the
aging process. We observed that a cytosolic factor protects the
proteasome from inhibition and also modulates its activity. In
addition, we present evidence that this cytosolic protective fac-
tor is transferrable and capable of protecting human, yeast, and
mouse proteasomes, promoting resistance to inhibition by tox-
ins and proteasome speciﬁc inhibitors and also augmenting their
activity even in the absence of inhibitory agents. Thus, protein
assembly that is capable of protecting proteasomes from an evo-
lutionarily diverse suite of organisms likely plays a pivotal role
in stress resistance and species longevity and may also contribute
to the ability of naked mole-rats to successfully defy the aging
process.
Blanka Rogina (University of Connecticut Health Center, USA)
presented “Indy mutations maintain ﬂy health and homeostasis.”
Indy (I’m not dead yet) encodes the ﬂy homolog of a mammalian
transporter of the Krebs cycle intermediates. Reduced Indy gene
activity has beneﬁcial effects on energy balance in mice, worms,
and ﬂies, and on worm and ﬂy longevity. In ﬂies, longevity exten-
sion is not associated with negative effects on fertility, mobility, or
metabolic rate. We and others show that Indy mutations extend
longevity by mechanism similar to calorie restriction. Some of
the hallmarks of these changes are altered intermediate nutri-
ent metabolism and increased mitochondrial biogenesis. These
changes have been found in ﬂy heads, thoraces, and the midguts.
The observed changes in midgut energy metabolism, speciﬁcally
decreased production of free radicals, results in preservation of
intestinal stem cell (ISC) homeostasis, which is characterized by
a decrease in age-associated accumulation of ISCs. Our studies
show a direct connection between changes in energy metabolism,
caused by the Indy mutation, and preservation of ISC homeostasis
and midgut integrity. The data suggest that Indy mutations pre-
serve homeostasis in tissues that contribute to extended health and
longevity.
Christopher D. Church (Harwell Science and Innovation Cam-
pus, Oxfordshire, UK) presented “The fat mass and obesity
associated gene (FTO) regulates body composition and energy
homeostasis.” Genome-wide association studies have identiﬁed
single nucleotide polymorphisms within the human FTO that
display strong association with obesity and type 2 diabetes. Indi-
viduals homozygous for the at-risk allele weigh, on average,
∼3 kg more than individuals with the low-risk allele and dis-
play increased food intake, including a preference for fat and
protein. Bioinformatic and in vitro analyses show that FTO
codes for a AlkB-like, Fe(II)- and 2-oxoglutarate-dependent
nucleic acid demethylase that catalyzes the demethylation of
3-methylthymine, N6-methyladenosine, and 3-methyluracil in
single-strandedDNAandRNA.Rodent studies havedemonstrated
a role for FTO in energy homeostasis and body composition.
Mice over-expressing Fto are obese, hyperphagic, and exhibit nor-
mal energy expenditure. Conversely, the constitutive germline
loss of Fto results in high perinatal lethality and a reduction
in body length, fat mass, and lean mass. More recently, we
have shown that inactivation of Fto in adult mice leads to
reduced body weight, primarily due to a loss of lean mass,
and lower RER. Furthermore, selective inactivation of Fto in
the hypothalamus, a key site for the nutritional regulation of
Fto expression, results in reduced food intake and body weight
gain. Additionally, in vitro experiments have identiﬁed that Fto
expression is dynamically regulated by essential amino acid avail-
ability, including glutamine, cysteine, and Met. The altered
substrate utilization and sensing of dietary macronutrients high-
light a critical role for FTO in regulating peripheral metabolism
and provide mechanistic insights into how FTO contributes to
obesity.
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